Sio Capital Management, LLC Erasca, Inc. Transaction History
Sio Capital Management, LLC
- $268 Million
- Q4 2024
A detailed history of Sio Capital Management, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Sio Capital Management, LLC holds 1,356,186 shares of ERAS stock, worth $1.86 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
1,356,186
Previous 2,219,186
38.89%
Holding current value
$1.86 Million
Previous $6.06 Million
43.81%
% of portfolio
1.27%
Previous 3.2%
Shares
4 transactions
Others Institutions Holding ERAS
# of Institutions
153Shares Held
227MCall Options Held
10.9KPut Options Held
65.1K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$26.6 Million2.92% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.7MShares$22.9 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$22.2 Million6.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$17.4 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA12.5MShares$17.1 Million4.12% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $167M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...